The mean Hb levels for the epoetin alfa group were significantly increased from baseline at all evaluations (P<0.001) and 78% of patients who received epoetin alfa demonstrated a complete response to anaemia treatment (Hb increase ⩾1 g dl−1 without transfusion within the previous 4 weeks). This evidence concerns the gene GSTM1 and anemia.